{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:13:02Z","timestamp":1770286382352,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T00:00:00Z","timestamp":1445817600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s00347-015-0141-4","type":"journal-article","created":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T10:41:11Z","timestamp":1445856071000},"page":"907-911","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Adjuvante Therapie und interdisziplin\u00e4re Nachsorge des Bindehautmelanoms","Adjuvant therapy and interdisciplinary follow-up care of conjunctival melanoma"],"prefix":"10.1007","volume":"112","author":[{"given":"L.M.","family":"Heindl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.R.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schlaak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mauch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cursiefen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,26]]},"reference":[{"key":"141_CR1","first-page":"539","volume-title":"AJCC cancer staging manual","author":"AJCC-UICC Ophthalmic Oncology Task Force","year":"2009","unstructured":"AJCC-UICC Ophthalmic Oncology Task Force (2009) Malignant melanoma of the conjunctiva. In: Edge SE, Byrd DR, Carducci MA et al (Hrsg) AJCC cancer staging manual, 7.\u00a0Aufl. Springer, New York, S\u00a0539\u2013546","edition":"7"},{"key":"141_CR2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.preteyeres.2013.01.001","volume":"34","author":"F Bock","year":"2013","unstructured":"Bock F, Maruyama K, Regenfuss B et al (2013) Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases. Prog Retin Eye Res 34:89\u2013124","journal-title":"Prog Retin Eye Res"},{"key":"141_CR3","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1177\/107327480401100505","volume":"11","author":"S Brownstein","year":"2004","unstructured":"Brownstein S (2004) Malignant melanoma of the conjunctiva. Cancer Control 11:310\u2013317","journal-title":"Cancer Control"},{"key":"141_CR4","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1442-9071.2006.01356.x","volume":"34","author":"R Chalasani","year":"2006","unstructured":"Chalasani R, Giblin M, Conway RM (2006) Role of topical chemotherapy for primary acquired melanosis and malignant melanoma of the conjunctiva and cornea: review of the evidence and recommendations for treatment. Clin Experiment Ophthalmol 34:708\u2013714","journal-title":"Clin Experiment Ophthalmol"},{"key":"141_CR5","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","volume":"364","author":"PB Chapman","year":"2011","unstructured":"Chapman PB, Hauschild A, Robert C et al (2011) Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364:2507\u20132516","journal-title":"N Engl J Med"},{"key":"141_CR6","doi-asserted-by":"crossref","first-page":"349162","DOI":"10.1155\/2013\/349162","volume":"2013","author":"VM Cohen","year":"2013","unstructured":"Cohen VM, Papastefanou VP, Liu S et al (2013) The use of strontium-90 beta radiotherapy as adjuvant treatment for conjunctival melanoma. J Oncol 2013:349162","journal-title":"J Oncol"},{"key":"141_CR7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/eye.2008.154","volume":"23","author":"B Damato","year":"2009","unstructured":"Damato B, Coupland SE (2009) An audit of conjunctival melanoma treatment in Liverpool. Eye 23:801\u2013809","journal-title":"Eye"},{"key":"141_CR8","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1586\/era.09.85","volume":"9","author":"B Damato","year":"2009","unstructured":"Damato B, Coupland SE (2009) Management of conjunctival melanoma. Expert Rev Anticancer Ther 9:1227\u20131239","journal-title":"Expert Rev Anticancer Ther"},{"key":"141_CR9","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/bjo.77.10.624","volume":"77","author":"P Potter De","year":"1993","unstructured":"De Potter P, Shields CL, Shields JA et al (1993) Clinical predictive factors for development of recurrence and metastasis in conjunctival melanoma: a review of 68 cases. Br J Ophthalmol 77:624\u2013630","journal-title":"Br J Ophthalmol"},{"key":"141_CR10","first-page":"289","volume":"15","author":"JJ Dutton","year":"1984","unstructured":"Dutton JJ, Anderson RL, Tse DT (1984) Combined surgery and cryotherapy for scleral invasion of epithelial malignancies. Ophthalmic Surg 15:289\u2013294","journal-title":"Ophthalmic Surg"},{"key":"141_CR11","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/bjo.2004.064204","volume":"89","author":"PT Finger","year":"2005","unstructured":"Finger PT (2005) \u201eFinger-tip\u201c cryotherapy probes: treatment of squamous and melanocytic conjunctival neoplasia. Br J Ophthalmol 89:942\u2013945","journal-title":"Br J Ophthalmol"},{"key":"141_CR12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ajo.2007.08.027","volume":"145","author":"PT Finger","year":"2008","unstructured":"Finger PT, Sedeek RW, Chin KJ (2008) Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex. Am J Ophthalmol 145:124\u2013129","journal-title":"Am J Ophthalmol"},{"key":"141_CR13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1203421","volume":"367","author":"KT Flaherty","year":"2012","unstructured":"Flaherty KT, Robert C, Hersey P et al (2012) Improved survival with MEK inhibition in BRAF-mutated melanoma. N Engl J Med 367:107\u2013114","journal-title":"N Engl J Med"},{"key":"141_CR14","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/archopht.1996.01100140461020","volume":"114","author":"J Frucht-Pery","year":"1996","unstructured":"Frucht-Pery J, Pe\u2019er J (1996) Use of mitomycin C in the treatment of conjunctival primary acquired melanosis with atypia. Arch Ophthalmol 114:1261\u20131264","journal-title":"Arch Ophthalmol"},{"key":"141_CR15","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1158\/1078-0432.CCR-13-0163","volume":"19","author":"KG Griewank","year":"2013","unstructured":"Griewank KG, Westekemper H, Murali R et al (2013) Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas. Clin Cancer Res 19:3143\u20133152","journal-title":"Clin Cancer Res"},{"key":"141_CR16","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s00347-002-0765-z","volume":"100","author":"MJ Groh","year":"2003","unstructured":"Groh MJ, Holbach LM, K\u00fchnel B et al (2003) Therapie maligner Melanome der Konjunktiva bei prim\u00e4r erworbener Melanose (PEM) mit Mitomycin-C-0,02\u2009%-Augentropfen. Ophthalmologe 100:708\u2013712","journal-title":"Ophthalmologe"},{"key":"141_CR17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ophtha.2009.06.057","volume":"117","author":"LM Heindl","year":"2010","unstructured":"Heindl LM, Hofmann TN, Adler W et al (2010) Intraocular tumor-associated lymphangiogenesis: a novel prognostic factor for ciliary body melanomas with extraocular extension? Ophthalmology 117:334\u2013342","journal-title":"Ophthalmology"},{"key":"141_CR18","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.ophtha.2011.05.025","volume":"118","author":"LM Heindl","year":"2011","unstructured":"Heindl LM, Hofmann-Rummelt C, Adler W et al (2011) Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva. Ophthalmology 118:2351\u20132360","journal-title":"Ophthalmology"},{"key":"141_CR19","doi-asserted-by":"crossref","first-page":"7074","DOI":"10.1167\/iovs.11-7902","volume":"52","author":"LM Heindl","year":"2011","unstructured":"Heindl LM, Hofmann-Rummelt C, Adler W et al (2011) Tumor-associated lymphangiogenesis in the development of conjunctival melanoma. Invest Ophthalmol Vis Sci 52:7074\u20137083","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"141_CR20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00417-009-1189-0","volume":"248","author":"TR Herold","year":"2010","unstructured":"Herold TR, Hintschich C (2010) Interferon alpha for the treatment of melanocytic conjunctival lesions. Graefes Arch Clin Exp Ophthalmol 248:111\u2013115","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"141_CR21","doi-asserted-by":"crossref","unstructured":"Hos D, Schlereth SL, Bock F et al (2015) Antilymphangiogenic therapy to promote transplant survival and to reduce cancer metastasis: what can we learn from the eye? Semin Cell Dev Biol 38:117\u2013130","DOI":"10.1016\/j.semcdb.2014.11.003"},{"key":"141_CR22","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0161-6420(88)33058-7","volume":"95","author":"FA Jakobiec","year":"1988","unstructured":"Jakobiec FA, Rini FJ, Fraunfelder FT et al (1988) Cryotherapy for conjunctival primary acquired melanosis and malignant melanoma: experience with 62 cases. Ophthalmology 95:1058\u20131070","journal-title":"Ophthalmology"},{"key":"141_CR23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1442-9071.2010.02469.x","volume":"39","author":"R Karim","year":"2011","unstructured":"Karim R, Conway RM (2011) Conservative resection and adjuvant plaque brachytherapy for early-stage conjunctival melanoma. Clin Experiment Ophthalmol 39:293\u2013298","journal-title":"Clin Experiment Ophthalmol"},{"key":"141_CR24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/bjo.86.1.31","volume":"86","author":"EG Kemp","year":"2002","unstructured":"Kemp EG, Harnett AN, Chatterjee S (2002) Preoperative topical and intraoperative local mitomycin C adjuvant therapy in the management of ocular surface neoplasias. Br J Ophthalmol 86:31\u201334","journal-title":"Br J Ophthalmol"},{"key":"141_CR25","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1167\/iovs.13-13254","volume":"55","author":"KR Koch","year":"2014","unstructured":"Koch KR, Refaian N, Hos D et al (2014) Autocrine impact of VEGF-A on uveal melanoma cells. Invest Ophthalmol Vis Sci 55:2697\u20132704","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"141_CR26","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1007\/s00417-004-1080-y","volume":"243","author":"M Kurli","year":"2005","unstructured":"Kurli M, Finger PT (2005) Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years\u2019 experience. Graefes Arch Clin Exp Ophthalmol 243:1108\u20131114","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"141_CR27","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1055\/s-0034-1387384","volume":"139","author":"M Kusch","year":"2014","unstructured":"Kusch M, Labouvie H, Hein-Nau B et al (2014) Integrierte Psychoonkologie: Implementierung eines psychoonkologischen Versorgungsprogramms am Centrum f\u00fcr Integrierte Onkologie K\u00f6ln Bonn, Standort K\u00f6ln. Dtsch Med Wochenschr 139:2357\u20132360","journal-title":"Dtsch Med Wochenschr"},{"key":"141_CR28","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1167\/iovs.10-6934","volume":"52","author":"SL Lake","year":"2011","unstructured":"Lake SL, Jmor F, Dopierala J et al (2011) Multiplex ligation-dependent probe amplification of conjunctival melanoma reveals common BRAF V600E gene mutation and gene copy number changes. Invest Ophthalmol Vis Sci 52:5598\u20135604","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"141_CR29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ophtha.2009.07.032","volume":"117","author":"A Lichtinger","year":"2010","unstructured":"Lichtinger A, Pe\u2019er J, Frucht-Pery J et al (2010) Limbal stem cell deficiency after topical mitomycin C therapy for primary acquired melanosis with atypia. Ophthalmology 117:431\u2013437","journal-title":"Ophthalmology"},{"key":"141_CR30","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2147\/OPTH.S38415","volume":"6","author":"LA Lim","year":"2013","unstructured":"Lim LA, Madigan MC, Conway RM (2013) Conjunctival melanoma: a review of conceptual and treatment advances. Clin Ophthalmol 6:521\u2013531","journal-title":"Clin Ophthalmol"},{"key":"141_CR31","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1055\/s-2002-35693","volume":"219","author":"PK Lommatzsch","year":"2002","unstructured":"Lommatzsch PK, Werschnik C (2002) Das maligne Melanom der Bindehaut. Klinische \u00dcbersicht mit Empfehlungen zur Diagnose, Therapie und Nachsorge. Klin Monbl Augenheilkd 219:710\u2013721","journal-title":"Klin Monbl Augenheilkd"},{"key":"141_CR32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1167\/iovs.04-0344","volume":"46","author":"GS Missotten","year":"2005","unstructured":"Missotten GS, Keijser S, De Keizer RJ et al (2005) Conjunctival melanoma in the Netherlands: a nationwide study. Invest Ophthalmol Vis Sci 46:75\u201382","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"141_CR33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ajo.2004.08.065","volume":"139","author":"J Pe","year":"2005","unstructured":"Pe\u2019er J, Frucht-Pery J (2005) The treatment of primary acquired melanosis (PAM) with atypia by topical Mitomycin C. Am J Ophthalmol 139:229\u2013234","journal-title":"Am J Ophthalmol"},{"key":"141_CR34","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00003226-200303000-00006","volume":"22","author":"T Rodriguez-Ares","year":"2003","unstructured":"Rodriguez-Ares T, Tourino R, De Rojas V et al (2003) Topical mitomycin C in the treatment of pigmented conjunctival lesions. Cornea 22:114\u2013117","journal-title":"Cornea"},{"key":"141_CR35","doi-asserted-by":"crossref","unstructured":"Satchi K, McKelvie P, McNab AA (2015) Malignant melanoma of the lacrimal drainage apparatus complicating conjunctival melanoma. Ophthal Plast Reconstr Surg 31:207\u2013210","DOI":"10.1097\/IOP.0000000000000256"},{"key":"141_CR36","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00347-008-1800-5","volume":"105","author":"M Schallenberg","year":"2008","unstructured":"Schallenberg M, Niederdr\u00e4ing N, Steuhl KP et al (2008) Topisches Mitomycin C als Therapie konjunktivaler Tumore. Ophthalmologe 105:777\u2013784","journal-title":"Ophthalmologe"},{"key":"141_CR37","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s00347-012-2736-3","volume":"110","author":"C Schumacher","year":"2013","unstructured":"Schumacher C, Heinz C, Lommatzsch P et al (2013) Interferon-\u03b12b zur Therapie des Bindehautmelanoms. Ein Fallbeispiel. Ophthalmologe 110:766\u2013769","journal-title":"Ophthalmologe"},{"key":"141_CR38","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/IOP.0b013e3182611670","volume":"28","author":"CL Shields","year":"2012","unstructured":"Shields CL, Kaliki S, Al-Dahmash SA et al (2012) American Joint Committee on Cancer (AJCC) clinical classification predicts conjunctival melanoma outcomes. Ophthal Plast Reconstr Surg 28:313\u2013323","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"141_CR39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.clindermatol.2014.10.010","volume":"33","author":"CL Shields","year":"2015","unstructured":"Shields CL, Kels JG, Shields JA (2015) Melanoma of the eye: revealing hidden secrets, one at a time. Clin Dermatol 33:183\u2013196","journal-title":"Clin Dermatol"},{"key":"141_CR40","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ophtha.2010.06.021","volume":"118","author":"CL Shields","year":"2011","unstructured":"Shields CL, Markowitz JS, Belinsky I et al (2011) Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases. Ophthalmology 118:389\u2013395","journal-title":"Ophthalmology"},{"key":"141_CR41","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0002-9394(01)01085-6","volume":"132","author":"CL Shields","year":"2001","unstructured":"Shields CL, Shields JA, Armstrong T (2001) Management of conjunctival and corneal melanoma with surgical excision, amniotic membrane allograft, and topical chemotherapy. Am J Ophthalmol 132:576\u2013578","journal-title":"Am J Ophthalmol"},{"key":"141_CR42","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00002341-199805000-00012","volume":"14","author":"JA Shields","year":"1998","unstructured":"Shields JA, Shields CL, de Potter P (1998) Surgical management of circumscribed conjunctival melanomas. Ophthalmic Plast Reconstr Surg 14:208\u2013215","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"141_CR43","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0161-6420(13)31630-3","volume":"100","author":"SM Tucker","year":"1993","unstructured":"Tucker SM, Hurwitz JJ, Pavlin CJ et al (1993) Scleral melt after cryotherapy for conjunctival melanoma. Ophthalmology 100:574\u2013577","journal-title":"Ophthalmology"},{"key":"141_CR44","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00000421-200206000-00009","volume":"25","author":"C Werschnik","year":"2002","unstructured":"Werschnik C, Lommatzsch PK (2002) Long-term follow-up of patients with conjunctival melanoma. Am J Clin Oncol 25:248\u2013255","journal-title":"Am J Clin Oncol"},{"key":"141_CR45","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00347-006-1341-8","volume":"103","author":"H Westekemper","year":"2006","unstructured":"Westekemper H, Anastassiou G, Sauerwein W et al (2006) Analyse der okul\u00e4ren Oberfl\u00e4che nach Protonenbestrahlung bei malignem Melanom der Bindehaut. Ophthalmologe 103:588\u2013595","journal-title":"Ophthalmologe"},{"key":"141_CR46","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1055\/s-0029-1246068","volume":"228","author":"H Westekemper","year":"2011","unstructured":"Westekemper H, Schallenberg M, Tomaszewski A et al (2011) Maligne epibulb\u00e4re Tumoren: Neue Strategien in Diagnostik und Therapie. Klin Monbl Augenheilkd 228:780\u2013792","journal-title":"Klin Monbl Augenheilkd"},{"key":"141_CR47","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00417-005-0093-5","volume":"244","author":"H Wuestemeyer","year":"2006","unstructured":"Wuestemeyer H, Sauerwein W, Meller D et al (2006) Proton radiotherapy as an alternative to exenteration in the management of extended conjunctival melanoma. Graefes Arch Clin Exp Ophthalmol 244:438\u2013446","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"141_CR48","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/archophthalmol.2011.2566","volume":"130","author":"YA Yousef","year":"2012","unstructured":"Yousef YA, Finger PT (2012) Predictive value of the seventh edition American Joint Committee on Cancer staging system for conjunctival melanoma. Arch Ophthalmol 130:599\u2013606","journal-title":"Arch Ophthalmol"},{"key":"141_CR49","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/01.IOP.0000055826.30486.CC","volume":"19","author":"VH Yuen","year":"2003","unstructured":"Yuen VH, Jordan DR, Brownstein S et al (2003) Topical mitomycin treatment for primary acquired melanosis of the conjunctiva. Ophthal Plast Reconstr Surg 19:149\u2013151","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"141_CR50","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1136\/bjo.2008.147355","volume":"93","author":"P Zimmermann","year":"2009","unstructured":"Zimmermann P, Dietrich T, Bock F et al (2009) Tumour-associated lymphangiogenesis in conjunctival malignant melanoma. Br J Ophthalmol 93:1529\u20131534","journal-title":"Br J Ophthalmol"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-015-0141-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-015-0141-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-015-0141-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T19:58:25Z","timestamp":1567281505000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-015-0141-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,26]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["141"],"URL":"https:\/\/doi.org\/10.1007\/s00347-015-0141-4","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,26]]}}}